Closing the Diagnostic Gap

Tuberculosis (TB) remains one of the world's deadliest infectious diseases, particularly in low- and middle-income countries (LMICs). Historically, TB control has been hindered by a massive "diagnostic gap," where slow, low-sensitivity sputum smear microscopy failed to detect drug-resistant strains or identify active cases in a timely manner. To address this, the World Health Organization (WHO) has updated its consolidated guidelines to recommend near-point-of-care (NPOC) molecular nucleic acid amplification tests (NAATs) as the initial diagnostic tool for all suspected cases.

While next-generation molecular platforms—such as Cepheid's GeneXpert and portable, low-complexity NAATs—offer PCR-quality sensitivity within hours, scaling these diagnostics globally is an immense operational challenge. Successfully deploying complex molecular testing systems in low-resource, rural environments depends on securing Operational Directors who possess deep experience in global health logistics and multilateral NGO partnerships.

Logistical Realities of Low-Resource Deployments

Deploying high-tech molecular diagnostics in remote clinics across high-burden countries (such as Kenya, Nigeria, Bangladesh, and Indonesia) requires overcoming severe environmental and infrastructural barriers:

• Infrastructural Deficits: Many rural clinics lack stable electricity, requiring operational leaders to source battery-supported or solar-powered diagnostic hardware and manage robust reagent shelf-life and cold-chain integrity.

• Sample Transport Networks: Establishing efficient, secure networks to transport patient swabs or sputum samples from remote communities to central referral hubs for secondary drug-resistance (DR-TB) confirmation.

• Stockout Prevention: Managing complex inventory and distribution pipelines to ensure a continuous supply of test cartridges and reagents, preventing clinical downtime in high-volume clinics.

Navigating Multilateral NGO Partnerships

Global diagnostics deployment is rarely funded or managed by a single corporate entity. Sponsoring firms must operate within a complex ecosystem of multilateral organisations, national ministries of health, and non-governmental organisations (NGOs):

• The Global Fund Initiative: A major 2026 initiative led by the Global Fund to Fight AIDS, Tuberculosis and Malaria is currently deploying nearly 3 million NPOC molecular diagnostic tests across 13 high-burden countries.

• Public-Private Collaboration: Managing collaborations with organisations like the Partnership for Supply Chain Management (PFSCM) and implementation NGOs (such as the Aurum Institute) to integrate new testing workflows into existing local health infrastructures.

• Access Pricing Models: Negotiating sustainable, at-cost cartridge pricing models with global donors to balance commercial viability with public health access mandates.

Sourcing Operational and Supply Chain Directors

Succeeding in global health markets requires an Operations Director or Supply Chain Lead with specific experience in international development and LMIC logistics. Executives from standard commercial laboratory backgrounds often struggle with the regulatory prequalification, tender processes, and infrastructural challenges of global health delivery.

RSA prioritises several core competencies when placing operational leadership in this sector:

• Global Health Logistics Track Record: A proven history of managing supply chains and medical device deployments in developing countries, navigating complex customs clearances, and establishing rural distribution networks.

• Multilateral Partnership Management: Experience working alongside the WHO, Global Fund, USAID, and local ministries of health to coordinate large-scale public health programmes.

• Local Capacity Integration: The ability to design and implement training programmes for local healthcare workers, ensuring diagnostic hardware is operated correctly and integrated with local clinical treatment pathways.

By securing operational leaders who can combine technical logistics expertise with relationship management in the NGO sector, diagnostics firms can bridge the gap between scientific innovation and community-level healthcare delivery, contributing to the global eradication of tuberculosis.